Epstein-Barr and MS: meta-analysis
March 5, 2014…hree anti-EBV antibodies: anti-EBV nuclear antigen 1 (anti-EBNA-1) or EBNA complex; antiviral capsid antigen (anti-VCA); and anti-Early Antigen (anti-EA). The median seroprevalence of anti-EBNA IgG was 98% in MS patients compared to 88% in controls (odds ratio 4.7). The median anti-VCA IgG seropositivity was 99% in MS patients versus 92% in controls (OR 4.51). In contrast, the median seroprevalence for anti-EA IgG was similar in cases and controls…